Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ulistin for Acute Kidney Injury in OPCAB
NCT04473144Unknown
- Sponsor
- Ajou University School of Medicine
- Start
- Aug 2020
- Primary completion
- Jul 2021
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Open-label trial of ulinastatin in acute kidney injury (AKI) (2 arms), sponsored by Ajou University School of Medicine. Primary endpoint: Incidence of Acute Kidney Injury at 7 days. Status: unknown.
02
Drugs
ulinastatin
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT04473144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04473144.